<DOC>
	<DOCNO>NCT02917499</DOCNO>
	<brief_summary>The goal study examine efficacy safety transcranial magnetic stimulation ( TMS ) deep TMS ( dTMS ) treatment different psychiatric neurological disorder . Subjects randomize two group : experimental ( treated pharmacotherapy TMS ) control group ( treat pharmacotherapy ) . They clinicians complete battery instrument measure relevant symptom , global functioning quality life . The first measurement do inclusion treatment . The second measurement make immediately end treatment ( 4 week ) . The measurement ( follow-up ) make 3 6 month .</brief_summary>
	<brief_title>Efficacy Safety TMS Deep TMS Treatment Psychiatric Neurological Disorders</brief_title>
	<detailed_description />
	<mesh_term>Mood Disorders</mesh_term>
	<criteria>diagnose psychiatric neurological disorder , duration disorder least 5 year , inpatient outpatient treat Psychiatric hospital Sveti Ivan suicidality , psychosis , alcohol addiction , unable complete questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>